Despite the extraordinary effectiveness of the current HPV VLP based vaccines in prevention they have no therapeutic value. Individuals already infected by a cancer associated HPV type are still at risk fro developing cancer. Dr Howley’s lab has been studying the pathway by which HPV targets p53 proteolysis with the goal of uncovering a therapeutic strategy.